Key Metrics
CiteScore 

2.7
H-Index 

62
Impact Factor 

< 5
SJR 

Q3Drug Discovery

SNIP 

0.56
Recommended pre-submission checks
Powered by 

Topics Covered on Assay and Drug Development Technologies
Assay and Drug Development Technologies Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | MARY ANN LIEBERT, INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2002 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Assay and Drug Development Technologies ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Assay and Drug Development Technologies
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer.
- 23 Jul 2026
- Assay and drug development technologies
Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.
- 1 Jul 2026
- Assay and drug development technologies
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.
- 25 Jun 2026
- Assay and drug development technologies
Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.
- 23 Jun 2026
- Assay and drug development technologies
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.
- 16 Jun 2026
- Assay and drug development technologies
Molecular Mechanism of μ-Opioid Receptor Activation.
- 18 Apr 2026
- Assay and drug development technologies
Integrated In Vivo and In Silico Approaches for Targeting JAK2/STAT3/SOCS3: Repurposing Boeravinone B and Resveratrol as Chemopreventive Agents in Colon Cancer.
- 23 Jul 2026
- Assay and drug development technologies
Indolizine Compound Selection for HPV Anticancer Active Prediction Using CNN Classifier with ADME Descriptors.
- 1 Jul 2026
- Assay and drug development technologies
Molecular Mechanisms and Optimization Strategies for the Impact of Antihypertensive, Lipid-Lowering, and Antidiabetic Drugs on Gut Microbiota.
- 25 Jun 2026
- Assay and drug development technologies
Identification of Broad-Spectrum Inhibitors Targeting Multiple Amyloidogenic Proteins Using Functional Group-Based Virtual Screening.
- 23 Jun 2026
- Assay and drug development technologies
Formulation, Characterization, and Biological Assessment of Embelin-Loaded Glycerosomes.
- 16 Jun 2026
- Assay and drug development technologies
Molecular Mechanism of μ-Opioid Receptor Activation.
- 18 Apr 2026
- Assay and drug development technologies
FAQs on Assay and Drug Development Technologies
How long has Assay and Drug Development Technologies been actively publishing? 
What is the publishing frequency of Assay and Drug Development Technologies? 
How many articles did Assay and Drug Development Technologies publish last year? 
What is the eISSN & pISSN for Assay and Drug Development Technologies? 
What is Citescore for Assay and Drug Development Technologies? 
What is the H Index for Assay and Drug Development Technologies ? 
What is SNIP score for Assay and Drug Development Technologies? 
What is the SJR for Assay and Drug Development Technologies? 
Who is the publisher of Assay and Drug Development Technologies? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary